https://straitsresearch.com/buy-now/psoriatic-arthritis-treatment-market
Psoriatic Arthritis Treatment Market Size, Share & Growth to 2033
The global psoriatic arthritis treatment market size is projected to grow from USD 12.90 billion in 2025 to USD 34.55 billion by 2033, exhibiting a CAGR of...
psoriatic arthritis treatmentmarket sizesharegrowth2033
https://www.arthritis.org/health-wellness/treatment/treatment-plan/disease-management/finding-the-optimal-psa-treatment
Finding the Optimal Psoriatic Arthritis Treatment | Arthritis Foundation
Oct 15, 2025 - Many medications and other treatment options are available to ease symptoms and slow disease progress of PsA. Read about some of the medications used to treat...
psoriatic arthritis treatmentfindingoptimalfoundation
https://www.hmpgloballearningnetwork.com/site/derm-app/videos/psoriatic-arthritis-treatment-update
Psoriatic Arthritis Treatment Update
Dr Joseph Merola discusses advancing psoriatic arthritis care beyond baseline treatment by focusing on long-term, holistic management. Videos
psoriatic arthritis treatmentupdate
https://www.researchandmarkets.com/reports/5671341/psoriatic-arthritis-treatment-market-forecast
Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027
psoriatic arthritis treatmentmarket forecastpipeline analysisepidemiology2022
https://www.hmpgloballearningnetwork.com/site/thederm/conference-coverage/psoriasis-and-psoriatic-arthritis-treatment-interleukin-inhibitors
Psoriasis and Psoriatic Arthritis Treatment: Interleukin Inhibitors
During Spring Dermatology Week 2024, Dr Joseph Merola delivered a compelling presentation titled "Enhancing Outcomes for Psoriasis and Psoriatic Arthritis: An...
psoriatic arthritis treatmentpsoriasisinterleukininhibitors
https://www.news-medical.net/news/2004/08/02/3719.aspx
European recommended approval of Remicade for treatment of psoriatic arthritis
Aug 2, 2004 - Committee for Medicinal Products for Human Use of the European Agency for the Evaluation of Medicinal Products has issued a positive opinion recommending...
europeanrecommendedapprovalremicadetreatment
https://www.nice.org.uk/guidance/ta220
Overview | Golimumab for the treatment of psoriatic arthritis | Guidance | NICE
Evidence-based recommendations on golimumab (Simponi) for treating psoriatic arthritis in adults
for thepsoriatic arthritisoverviewgolimumabtreatment
https://www.hmpgloballearningnetwork.com/site/thederm/fda-alerts/fda-approves-sotyktu-treatment-adults-active-psoriatic-arthritis
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis. FDA Alerts
for the